Track topics on Twitter Track topics that are important to you
425 Park Avenue
United States of America
Phone: (212) 836-8000
Fax: (212) 836-8689
Click Therapeutics has appointed Randall Kaye to serve as its chief medical officer. Kaye comes to Click from SSI Strategy, where he was chief scientific officer. New York-based Click also appointed A...
Ed Kaye stepped aside from Sarepta Therapeutics (NASDAQ: SRPT) last year after leading the company through one of the most noteworthy and controversial drug approvals in recent memory, for the Duchenn...
DLA Piper Canada partner Adv. Noam Goodman and iCan founder Saul Kaye speak to "Globes" about the cannabis opportunities Israel is missing.
- Dr. Randall Kaye and Austin Speier Join Executive Team - Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical...
Stoke Therapeutics, Inc., today announced that veteran biotech executive Arthur Tzianabos, Ph.D., who has extensive experience in the development and commercialization of r...
On Wednesday, October 10, Kennedy Krieger Institute will salute pioneering news anchor Judy Woodruff, whose experience supporting her eldest son after a traumatic brain injury ins...
Here, we report a case of 3 year girl with d-TGA with IVS managed by Damus-Kaye-Stansel with right bidirectional. cavopulmonary anastomosis in first stage to train LV followed by definitive surgery (a...
Although all coronary anatomy in D-transposition of the great arteries may be "switchable," there are reports in the literature of early and late coronary obstruction following the arterial switch ope...
The Damus-Kaye-Stansel (DKS) anastomosis was originally described for the treatment of transposition of the great arteries but it is now used mainly for the treatment of single ventricle anomalies in ...
All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-...
Company History | Welcome to Kaye/Bassman International Corp. (KBIC). Our organization was founded in 1981 with a mission of positively impacting companies and enhancing careers by providing the fines...
The Partnership Fund for New York City is the $115 million investment arm of the Partnership for New York City (www.pfnyc.org). The Fundâs mission is to engage the Cityâ...
Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourneâs Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...
We have published hundreds of Kaye Scholer news stories on BioPortfolio along with dozens of Kaye Scholer Clinical Trials and PubMed Articles about Kaye Scholer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kaye Scholer Companies in our database. You can also find out about relevant Kaye Scholer Drugs and Medications on this site too.